Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

COVID-19 reinfection may trigger alopecia areata.

COVID-19 infection may cause hair loss.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Understanding how acne develops in different diseases could lead to new treatments.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

People with Collagen VI-related myopathies may often have hair loss and scalp issues.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

COVID-19 may worsen hair loss, but treatments like minoxidil can help.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Tea, especially green tea, shows promise in cosmetics for skin and hair benefits but more research is needed for effective use.

Some drugs may help treat both COVID-19 and radiation injury.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

A girl with skin rashes and low zinc levels improved with zinc supplements and had new gene mutations linked to her condition.

COVID-19 can cause skin problems.

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document suggests that Alopecia X in dogs is mainly a cosmetic issue and might be better left untreated.

Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.